PRELUDE CAPITAL MANAGEMENT, LLC - KARYOPHARM THERAPEUTICS INC ownership

KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 141 filers reported holding KARYOPHARM THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.42 and the average weighting 0.1%.

Quarter-by-quarter ownership
PRELUDE CAPITAL MANAGEMENT, LLC ownership history of KARYOPHARM THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$28,520
-82.7%
15,933
-62.4%
0.00%
-80.0%
Q1 2023$165,041
-17.1%
42,427
-27.5%
0.01%0.0%
Q4 2022$199,016
+168.9%
58,534
+333.9%
0.01%
+233.3%
Q3 2022$74,000
+39.6%
13,491
+14.4%
0.00%
+50.0%
Q2 2022$53,000
-60.7%
11,793
-43.8%
0.00%
-33.3%
Q4 2021$135,000
+10.7%
21,0000.0%0.00%0.0%
Q3 2021$122,000
-43.8%
21,0000.0%0.00%
-50.0%
Q2 2021$217,000
-1.8%
21,0000.0%0.01%0.0%
Q1 2021$221,000
-22.5%
21,000
+14.1%
0.01%
-14.3%
Q4 2020$285,000
+5.9%
18,4000.0%0.01%
-46.2%
Q3 2020$269,000
-25.3%
18,400
-3.3%
0.01%
-35.0%
Q2 2020$360,000
+11900.0%
19,025
+13686.2%
0.02%
Q4 2019$3,000
-66.7%
138
-90.9%
0.00%
Q2 2019$9,000
+350.0%
1,524
+383.8%
0.00%
Q1 2019$2,000
-33.3%
315
-11.8%
0.00%
Q4 2018$3,000
-62.5%
357
-28.0%
0.00%
Q3 2018$8,000
+60.0%
496
+78.4%
0.00%
Q2 2018$5,000
-81.5%
278
-86.1%
0.00%
-100.0%
Q1 2018$27,000
+35.0%
2,000
+11.1%
0.00%0.0%
Q3 2017$20,000
-93.4%
1,800
-94.4%
0.00%
-94.6%
Q4 2016$303,00032,1960.04%
Other shareholders
KARYOPHARM THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
AIGH Capital Management LLC 1,773,474$2,376,4561.12%
AlphaCentric Advisors LLC 1,125,000$1,507,5000.86%
Tejara Capital Ltd 1,077,388$1,443,7000.82%
Palo Alto Investors LP 5,675,876$7,605,6740.72%
Birchview Capital, LP 571,832$766,2550.65%
Altium Capital Management LP 740,000$991,6000.52%
Avidity Partners Management LP 8,298,570$11,120,0840.45%
Worth Venture Partners, LLC 445,981$597,6150.36%
SILVERARC CAPITAL MANAGEMENT, LLC 561,955$753,0200.23%
DAFNA Capital Management LLC 192,678$258,1890.08%
View complete list of KARYOPHARM THERAPEUTICS INC shareholders